Gladstone Institutional Advisory LLC Aurinia Pharmaceuticals Inc. Transaction History

Gladstone Institutional Advisory LLC

$2.1 Billion
Q4 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$5.94 - $11.27 $14,850 - $28,175	-2,500 Reduced 12.63%	17,300 $189,000
Q4 2022 Feb 01, 2023	SELL	$4.11 - $8.14 $136,863 - $271,062	-33,300 Reduced 62.71%	19,800 $85,000
Q3 2022 Jan 27, 2023	SELL	$6.66 - $12.39 $128,538 - $239,127	-19,300 Reduced 26.66%	53,100 $399,000
Q3 2022 Oct 20, 2022	SELL	$6.66 - $12.39 $128,538 - $239,127	-19,300 Reduced 26.66%	53,100 $399,000
Q2 2022 Jan 27, 2023	SELL	$8.95 - $12.8 $62,649 - $89,600	-7,000 Reduced 8.82%	72,400 $728,000
Q2 2022 Aug 15, 2022	SELL	$8.95 - $12.8 $62,649 - $89,600	-7,000 Reduced 8.82%	72,400 $728,000
Q1 2022 Jan 27, 2023	SELL	$10.05 - $22.48 $233,160 - $521,536	-23,200 Reduced 22.61%	79,400 $983,000
Q1 2022 May 04, 2022	SELL	$10.05 - $22.48 $233,160 - $521,536	-23,200 Reduced 22.61%	79,400 $983,000
Q4 2021 Jan 27, 2023	BUY	$17.78 - $33.08 $464,058 - $863,388	26,100 Added 34.12%	102,600 $2.35 Million
Q4 2021 Feb 11, 2022	BUY	$17.78 - $33.08 $464,058 - $863,388	26,100 Added 34.12%	102,600 $2.35 Million
Q3 2021 Jan 27, 2023	SELL	$10.93 - $23.55 $139,904 - $301,440	-12,800 Reduced 14.33%	76,500 $1.69 Million
Q3 2021 Nov 15, 2021	SELL	$10.93 - $23.55 $139,904 - $301,440	-12,800 Reduced 14.33%	76,500 $1.69 Million
Q1 2021 Jan 27, 2023	SELL	$12.3 - $18.73 $30,135 - $45,888	-2,450 Reduced 2.67%	89,300 $1.16 Million
Q1 2021 May 17, 2021	SELL	$12.3 - $18.73 $30,135 - $45,888	-2,450 Reduced 2.67%	89,300 $1.16 Million
Q4 2020 Jan 27, 2023	BUY	$12.94 - $16.05 $245,860 - $304,950	19,000 Added 26.12%	91,750 $1.27 Million
Q4 2020 Feb 16, 2021	BUY	$12.94 - $16.05 $245,860 - $304,950	19,000 Added 26.12%	91,750 $1.27 Million
Q3 2020 Jan 27, 2023	BUY	$13.19 - $16.66 $259,183 - $327,369	19,650 Added 37.01%	72,750 $1.07 Million
Q3 2020 Nov 16, 2020	BUY	$13.19 - $16.66 $143,111 - $180,761	10,850 Added 17.53%	72,750 $1.07 Million
Q2 2020 Aug 17, 2020	BUY	$14.12 - $18.33 $98,811 - $128,273	6,998 Added 12.75%	61,900 $1.01 Million
Q1 2020 May 14, 2020	BUY	$11.34 - $21.46 $622,588 - $1.18 Million	54,902 New	54,902 $797,000

Others Institutions Holding AUPH

# of Institutions

214

Shares Held

58.3M

Call Options Held

1.14M

Put Options Held

1.51M

Black Rock Inc. New York, NY

9.27M
Shares

$73.9 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

8.2M
Shares

$65.4 Million
1.0% of portfolio
Tang Capital Management LLC San Diego, CA

7.23M
Shares

$57.6 Million
4.52% of portfolio
Nea Management Company, LLC Timonium, MD

3.97M
Shares

$31.6 Million
2.22% of portfolio
State Street Corp Boston, MA

2.95M
Shares

$23.5 Million
0.0% of portfolio

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.13B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gladstone Institutional Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gladstone Institutional Advisory LLC with notifications on news.

Account